Synapse - Find an Expert

5913 Results

Targetable alterations and rare fusions in sarcomas identified by custom RNA sequencing

Meeting Abstract

Mata, D.; Benayed, R.; Mullaney, K.; Rios, K.; Agaram, N.; Arcila, M.; Ladanyi, M.; Hameed, M.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Cytoreductive nephrectomy for high-risk patients

Meeting Abstract

Silagy, A.; Mano, R.; Holmes, A.; Attalla, K.; Dinatale, R.; Marcon, J.; Motzer, R.; Coleman, J.; Russo, P.; Hakimi, A. A.
BJU International (2020)

Fulltext@MSK | Save

The impact of intraoperative opioid, ketamine and dexmedetomidine administration on oncologic outcomes following kidney cancer surgery

Meeting Abstract

Silagy, A.; Hannum, M.; Coleman, J.; Russo, P.; Tan, K. S.; Fischer, G.; McCormick, P.; Hakimi, A. A.; Mincer, J.
BJU International (2020)

Fulltext@MSK | Save

Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients

Meeting Abstract

Thompson, J.; Ren, Y.; Romero, K.; Lew, M.; Bush, A.; Messina, J.; Jung, S. H.; Miller, J.; Zenko, Z.; Jenq, R. R.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Chemotherapy and inflammation induced damage of intestinal epithelium is associated with increased T cell chemotaxis

Meeting Abstract

Jansen, S. A.; van Hoesel, M.; Mokry, M.; Sierra, L. S.; Takashima, S.; Nieuwenhuis, E. E.; Hanash, A. M.; Lindemans, C. A.
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia

Meeting Abstract

Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract

Meeting Abstract

Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Sandhu, K. S.; Barker, J. N.; Shia, J.; Yan, X; Daley, W. L.; Moore, G.; Fatmi, S.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)